Adrenal hyperandrogenism does not deteriorate insulin resistance and lipid profile in women with PCOS.

OBJECTIVE

The aim of this study was to investigate the impact of adrenal hyperandrogenism on insulin resistance and lipid profile in women with polycystic ovary syndrome (PCOS).

PATIENTS AND METHODS

We studied 372 women with PCOS according to the NIH criteria. 232 age- and BMI-matched women served as controls in order to define adrenal hyperandrogenism (DHEA-S >95th percentile). Then, patients with PCOS were classified into two groups: with adrenal hyperandrogenism (PCOS-AH,  = 108) and without adrenal hyperandrogenism (PCOS-NAH,  = 264). Anthropometric measurements were recorded. Fasting plasma glucose, insulin, lipid profile, sex hormone-binding globulin (SHBG) and androgen (TT, Δ4A, DHEA-S) concentrations were assessed. Free androgen index (FAI) and homeostatic model assessment-insulin resistance (HOMA-IR) index were calculated.

RESULTS

Women with PCOS-AH were younger than PCOS-NAH ( < 0.001), but did not differ in the degree and type of obesity. No differences were found in HOMA-IR, total cholesterol, HDL-c, LDL-c and triglyceride concentrations (in all comparisons,  > 0.05). These metabolic parameters did not differ between the two groups even after correction for age. Women with PCOS-AH had lower SHBG (29.2 ± 13.8 vs 32.4 ± 11.8 nmol/L,  = 0.025) and higher TT (1.0 ± 0.2 vs 0.8 ± 0.4 ng/mL,  = 0.05) and Δ4A (3.9 ± 1.2 vs 3.4 ± 1.0 ng/mL,  = 0.007) concentrations, as well as FAI (14.1 ± 8.0 vs 10.2 ± 5.0,  < 0.001). These results were confirmed by a multiple regression analysis model in which adrenal hyperandrogenism was negatively associated with age ( < 0.001) and SHBG concentrations ( = 0.02), but not with any metabolic parameter.

CONCLUSIONS

Women with PCOS and adrenal hyperandrogenism do not exhibit any deterioration in insulin resistance and lipid profile despite the higher degree of total androgens.